EDMONTON, AB Jan. 31, 2012 -- Consistent with prior communications from ILJIN, Isotechnicka Pharma Inc. is pursuing discussions with ILJIN Life Science Co., Ltd. to potentially change the current relationship with ILJIN in order to better advance the voclosporin program.